
    
      This is a multicentre clinical study conducted in the United Kingdom. It is an open label
      study designed to investigate objective response rate (RR), the time to progression (TTP) and
      the duration of tumor response in patients with colorectal cancer when treated with CP-4055.
      The quantitative and qualitative toxicities of the treatment will also be assessed.
    
  